Inventaire - your friends and communities are your best library - Inventaire

Clofarabine in pediatric acute leukemia: current findings and issues

published in: Pediatric Blood Cancer

date of publication: 2012-02-21

language: English

main subject: leukemia, acute leukemia

Cites articles 21

Date

Title

Authors

2011-10-03

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

Paul S. Gaynon
2010-04-19

Outcomes for children and adolescents with cancer: challenges for the twenty-first century

Nita L Seibel
2010-02-01

Clofarabine in leukemia

Hagop Kantarjian, Stefan Faderl, Elias Jabbour, William Plunkett, Hady Ghanem
2010-04-12

European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy

Robert K Hills
2010-04-26

Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome

Hagop Kantarjian, Stefan Faderl, Zeev Estrov, Susan O'Brien, Farhad Ravandi, Gautam Borthakur, Guillermo Garcia-Manero, Jorge Eduardo Cortes, William Plunkett, Monica Kwari
2010-07-20

Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition

Berthold Gottgens, Jeffrey Craig, Carlo Gambacorti-Passerini, Nick Wong, Vera Magistroni, Richard B Lock, Richard Saffery
2009-09-10

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

Lauren Silverman, Paul S. Gaynon
2009-08-29

Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia

Franco Locatelli
2008-10-01

Clofarabine combinations as acute myeloid leukemia salvage therapy

Hagop Kantarjian, Alessandra Ferrajoli, Stefan Faderl, Zeev Estrov, Srdan Verstovsek, William G Wierda, Farhad Ravandi, Gautam Borthakur, Xuelin Huang, Monica Kwari
2008-08-01

Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]

Stephen P Hunger, Paul S. Gaynon
2007-06-11

A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias
2006-01-10

Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older.

Hagop Kantarjian, Alessandra Ferrajoli, Stefan Faderl, Zeev Estrov, Srdan Verstovsek, William G Wierda, Susan O'Brien, Farhad Ravandi, Guillermo Garcia-Manero, Jorge Eduardo Cortes, Francis J Giles, Monica Kwari
2006-10-01

Discovery and development of clofarabine: a nucleoside analogue for treating cancer
2005-05-01

The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog

Hagop Kantarjian, Stefan Faderl, Michael J. Keating, William Plunkett, Sima Jeha
2004-10-14

Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.

Hagop Kantarjian, Alessandra Ferrajoli, Stefan Faderl, Zeev Estrov, William G Wierda, Susan O'Brien, Guillermo Garcia-Manero, Jorge Eduardo Cortes, Michael J. Keating, William Plunkett, Elihu Estey, Francis J Giles, Monica Kwari, Peter L Bonate
2003-03-01

Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.

Hagop Kantarjian, Stefan Faderl, Jorge Eduardo Cortes, Susan O'Brien, Mary Beth Rios, Francis Giles, Michael J. Keating, William Plunkett, Fadlo R Khuri, Sima Jeha, Peter J McLaughlin
2003-06-05

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

Hagop Kantarjian, Stefan Faderl, Srdan Verstovsek, Jorge Eduardo Cortes, Susan O'Brien, Francis Giles, Guillermo Garcia-Manero, Michael J. Keating, William Plunkett, Sima Jeha
2003-10-09

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia

Hagop Kantarjian, Michael J. Keating, William Plunkett
2000-01-01

Preclinical antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)adenine (Cl-F-ara-A).
1992-01-24

Synthesis and biologic activity of 2'-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine,Synthesis and biological activity of 2'-fluoro-2-halo derivatives of 9-.beta.-D-arabinofuranosyladenine
1992-04-01

Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine

Article - wd:Q37987061

Welcome to Inventaire

the library of your friends and communities

you are offline